Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

Tempus and NYU Langone Health have formed a multi-year strategic collaboration to advance cancer research through molecular profiling and data-driven insights. The partnership will support NYU Langone ...

To kick off our three-part immuno-oncology webinar series, Dr. Cawley will highlight recent advancements driven by next-generation sequencing that may lead to a deeper understanding of the cancer ...

CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, June 2, 2024 /EINPresswire.com/ -- Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the ...

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma A retrospective cohort study was conducted at Chris ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...